GENE ONLINE|News &
Opinion
Blog

Lung Cancer
Trials & Approvals Anti-PD-L1
Roche’s Tecentriq Bags Landmark FDA Approval as First-Line Monotherapy for Metastatic NSCLC
2020-05-20
Technology CRISPR
CRISPR-Edited T cells Evaluated in Combating Lung Cancer
2020-05-10
R&D
AACR 2020 Conference – Advances in the Field of Lung Cancer Targeted Therapies
2020-04-28
R&D Lung Cancer
The Evolution of Lung Cancer Therapies at a Glance
2020-04-16
Trials & Approvals EGFR
Overwhelming Efficacy Allows AstraZeneca to End Cancer Drug Trial Sooner
2020-04-12
Trials & Approvals Lung Cancer
Japan Approves World’s First Therapy for Metastatic Non–Small Cell Lung Cancer with METex14
2020-03-26
Trials & Approvals Lung Cancer
Janssen Bags FDA Breakthrough Therapy Designation for Lung Cancer Drug
2020-03-12
Trials & Approvals EGFR
Vizimpro bags EU approval for NSCLC treatment
2019-04-16
Ranking & Reports Lung Cancer
Weekly Top 5 in China (0210-0216)
2019-02-18
Trials & Approvals Antibody
Tecentriq bags yet another FDA approval, this time as a combo therapy for NSCLC
2018-12-24
Trials & Approvals Lung Cancer
Pembrolizumab Upstages Topline PD-1/L1 drugs in lung cancer tussle
2018-11-06
R&D
A new player emerges in the non-small cell lung cancer (NSCLC) therapy scene
2018-10-11
Technology Lung Cancer
Fighting Lung Cancer with Precision Warfare
2018-06-21
1 2 3
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top